HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET ANALYSIS

Regional Analysis

Global High- Intensity Focused Ultrasound (HIFU) Market- Regional Analysis

Among regions, North America is expected to dominate the market over the forecast period,  due to the increasing prevalence of vaginal and vulvar cancer in that region. For instance, according to the Centers for Disease Control and Prevention, in November 2022, in U.S., 1,368 women were diagnosed with vaginal cancer and 5,579 women were diagnosed with vulvar cancer in 2019.

Europe is expected to hold second position in global high-intensity focused ultrasound (HIFU) market over the forecast period due to increasing collaborations by key players in that region. For instance, in June 2021, Theraclion, a France- based company developing a scalable robotic platform for non-invasive ultrasound therapy, announced a phase-2 collaboration with the University of Virginia Cancer Center. This will expand research activity in the use of Theraclion’s HIFU system in the treatment of early-stage breast cancer.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa